Energy Leadership Pharmaceuticals Skills 
Center for Creative Leadership
AUGUST 26, 2019
Our series of industry trend research reports — created using our flagship 360-assessment tool, Benchmarks® for Managers — shows that great similarities exist among leaders across industries including healthcare, pharmaceutical, financial, tech, energy, and government (civilian). Army Leadership Trend Report. View the U.S.
N2Growth Blog
FEBRUARY 4, 2015
No matter how fast the horse is, if you don’t have the right jockey with the right skills, victory will elude you. Strategy should include, inform, and integrate with leadership development, talent management, organization design, and proactive culture management. That is the good news.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Marshall Goldsmith
FEBRUARY 24, 2014
Before the energy conglomerate’s collapse in 2001, I had the opportunity to review Enron’s values. The pharmaceutical company is famous for its Credo, which was written many years ago and reflected the sincere values of the leaders of the company at that time. Enron is a great example.
Harvard Business Review
OCTOBER 22, 2013
With this in mind, we started to document and study the best-in-class skills of our client companies and their intrapreneurs. Here are five power skills we discovered to help you find uncontested space. Let’s say you’re in the energy sector. Teach these five power skills to the leaders and top talent in your organization.
Harvard Business Review
FEBRUARY 2, 2015
The factory floor at Pittsburgh’s Aquion Energy doesn’t look much like the steel mills that once populated this Rust Belt city. This is the kind of technology—and the type of firm—that will make renewable energy more efficient and more cost-effective. Aquion is a modern success story for American industry.
Harvard Business Review
OCTOBER 29, 2012
The nay-sayers, on the other hand, can cite the passionately defended view of the pharmaceutical industry that the cost of discovering innovative disease-curing molecules has been rising crazily — the basis for perennial campaigns for stronger intellectual property rights to safeguard pharma investments.
Harvard Business Review
SEPTEMBER 15, 2014
As Linda Hill and her colleagues have described, the company needed expert knowledge as it navigated the technically and ethically challenging waters of pharmaceutical development and marketing. The more responsible participants feel, the more energy and drive they’ll offer — and the better they’ll feel about participating.
Expert insights. Personalized for you.
57 
Let's personalize your content